Kundl, Austria

Andrea Thaler

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Andrea Thaler

Introduction: Andrea Thaler, an accomplished inventor based in Kundl, Austria, has made significant contributions to the pharmaceutical field through her inventions. With a total of three patents to her name, Thaler demonstrates a profound commitment to advancing medical science, particularly in treatments addressing anemia and viral infections.

Latest Patents: Thaler's work includes innovative patents that focus on complex medicinal compounds. One of her latest inventions involves multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor. This patent details crystalline compounds comprising vadadustat and L-proline, as well as methods for their preparation. Moreover, it outlines a pharmaceutical composition that can serve as a medicament for the treatment and prevention of anemia, especially in patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD).

Another notable patent from Thaler is related to crystalline forms of cabotegravir sodium. This invention opens avenues for effective treatment options, detailing methods for preparing these crystalline forms and including pharmaceutical compositions with at least one pharmaceutically acceptable excipient. This composition can be particularly beneficial for treating or preventing viral infections such as HIV.

Career Highlights: Throughout her career, Andrea Thaler has worked with prominent organizations, including Sandoz AG, contributing to her expertise in pharmaceutical development. Her innovative spirit and meticulous approach have positioned her as a notable figure in the realm of drug formulation and delivery systems.

Collaborations: Andrea has collaborated with talented peers in the industry, including Verena Adamer and Andreas Hotter. Her teamwork with these individuals has further enriched her research and development contributions, fostering a collaborative environment that encourages ingenious solutions in healthcare.

Conclusion: Andrea Thaler's dedication to innovation in the pharmaceutical sector is visible in her impactful patents. Her work addresses critical medical needs, paving the way for advancements in treatment for anemia and viral infections. As she continues her journey, Thaler is likely to remain a prominent figure in the field of medicinal chemistry and pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…